
SynBioBeta 2026 Speaker
Tony Day
Hawkwood Biotech
Founding Partner
Tony Day is a biotechnology executive and advisor with more than 30 years of experience building companies and commercializing breakthrough technologies at the intersection of biology, chemistry, and consumer products. He currently serves as Venture Partner at Genoa Ventures and is Co-founder and partner at Hawkwood Biotech, where he advises emerging and established companies on scale-up, strategy, partnerships, and market entry across industrial biotech, food tech, and sustainable ingredients.He started his career in R&D at the industrial enzyme company Genencor (now part of IFF) and following that an early employee and senior executive at Solazyme, where he served as Head of R&D and later VP of Commercialization. His work spans enzymology, molecular genetics, sustainability, regulatory strategy, and the translation of laboratory innovation into scalable manufacturing platforms.At this panel, Tony brings a rare perspective on how biosurfactants can move from promising molecules to scaled, market-shaping products.



Reagan
Jarvis
Anocca AB
CEO, Co-founder

Alex
Rives
CZI Biohub
Head of Science

Karenโฏ
Akinsanya
Schrodinger
President, R&D โ Therapeutics

Christopher
Arendt
Takeda
CSO, Head of Research

Stef
van Grieken
Cradle
CEO

Michael
Koeris
DARPA
Director, BTO

Jennifer
Dionne
Pumpkinseed
CEO

Daniyal
Hussain
GSK
Exec. Dir., Tech BD

Cynthia
Hong
Novartis
Dir., Search & Evaluation
SynBioBeta 2027 May 3-6, San Jose, California


